/

/

Newsletter Pricing

Sign in Sign up

You're using the beta version. You're using the beta version of the new website.

Prometheus Biosciences, Inc.

RXDX US

RXDX USPrometheus Biosciences, Inc.

United States Composite

Summary Financials Ratios Transcripts Classic View

Footer

Found an error or have an idea?
or write us an email to [email protected]

Company

About
Pricing
Blog

Support

Knowledge Base
FAQ

Legal

Privacy Policy

© 2024 Roic AI, Inc. All rights reserved.

Next Earnings

May 13

YTD Yield

-100.00%

3Y Yield

-100.00%

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Company Description

Address
CIK: 0001718852
Business

- -

USD

- -

- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years

5 years

1 year

Sales/Revenue/Turnover

- -

- -

- -

Net Income, GAAP

- -

- -

- -

Free Cash Flow

- -

- -

- -

Total Cash Common Dividend

- -

- -

- -

Total Equity

- -

- -

- -

Working Capital

FRC

•

in mil. unless spec.

Total Current Assets

Cash, Cash Equivalents & STI

Accounts Receivable, Net

Inventories

Total Current Liabilities

Payables & Accruals

ST Debt

Deferred Revenue

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1

Q2

Q3

Q4

FY

-Infinity

- -

- -

- -

- -

- -

-Infinity

- -

- -

- -

- -

- -

-Infinity

- -

- -

- -

- -

- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1

Q2

Q3

Q4

FY

-Infinity

- -

- -

- -

- -

- -

-Infinity

- -

- -

- -

- -

- -

-Infinity

- -

- -

- -

- -

- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1

Q2

Q3

Q4

FY

-Infinity

- -

- -

- -

- -

- -

-Infinity

- -

- -

- -

- -

- -

-Infinity

- -

- -

- -

- -

- -

Capital Structure

FRC

•

in mil. unless spec.

ST Debt

LT Borrowings

LT Finance Leases

Preferred Equity and Hybrid Capital

Shares Outstanding

Market Capitalization